Matthew Triplette, M.D., M.P.H.

Matthew Triplette M.D., M.P.H.
faculty member

Matthew Triplette, M.D., M.P.H.

Assistant Professor
Clinical Research Division, Fred Hutch

Fax: 206.667.5765
Mail Stop: D5-360

Dr. Matthew Triplette is a pulmonologist who studies how best to implement lung cancer screening to save the most lives. He explores the barriers and facilitators to screening as well as potential disparities. Dr. Triplette also studies lung disease and lung cancer in underserved and at-risk populations, including immunosuppressed patients with HIV or prior organ transplant.

Other Appointments & Affiliations

Assistant Professor, Division of Pulmonary, Critical Care and Sleep Medicine
University of Washington School of Medicine

Attending Physician
Seattle Cancer Care Alliance

Education

M.P.H., Health Care and Prevention, University of North Carolina, Chapel Hill, 2010

M.D., University of North Carolina, Chapel Hill, 2011

Internship, Internal Medicine, University of California, San Francisco, 2011-2012

Residency, Internal Medicine, University of California, San Francisco, 2012-2014

Graduate studies, Epidemiology, University of Washington, 2015-2016

Fellowship, Pulmonary and Critical Care Medicine, University of Washington, 2014-2017

Current Projects

COALS: Community-based Outcomes and Adherence for Lung cancer Screening

PEARLS: Patient Experiences with Adherence and navigation Resources in Lung cancer Screening

Research Focus

Dr. Triplette has studied racial disparities in coronary artery disease, chronic lung disease in HIV patients, and community-based screening for HIV and lung cancer. His current collaborative studies focus on lung cancer screening practices in underserved and at-risk populations. He is leading University of Washington/Seattle Cancer Care Alliance efforts to examine the current implementation of lung cancer screening and better understand barriers, facilitators and potential disparities in screening practices. He is part of an ongoing clinical study of biomarkers of lung-related disease and has an ongoing interest in lung cancer in special at-risk populations, including immunosuppressed patients with HIV or prior organ transplant.

 

Find A Clinical Trial

For the Media

The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.

Email media@fredhutch.org or call 206.667.2210